The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antiemetics-Global Market Insights and Sales Trends 2024
Synopsis
The global Antiemetics market size is expected to reach US$ 4931.5 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Antiemetics in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others, are propelling Antiemetics market. 5-HT3 receptor antagonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dopamine antagonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antiemetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antiemetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antiemetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antiemetics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antiemetics covered in this report include GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson and Baxter, etc.
The global Antiemetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter
Global Antiemetics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antiemetics market, Segment by Type:
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others
Global Antiemetics market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Antiemetics market size is expected to reach US$ 4931.5 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Antiemetics in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others, are propelling Antiemetics market. 5-HT3 receptor antagonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dopamine antagonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antiemetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antiemetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antiemetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antiemetics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antiemetics covered in this report include GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson and Baxter, etc.
The global Antiemetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter
Global Antiemetics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antiemetics market, Segment by Type:
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others
Global Antiemetics market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antiemetics Market Overview
1.1 Antiemetics Product Overview
1.2 Antiemetics Market Segment by Type
1.2.1 5-HT3 receptor antagonists
1.2.2 Dopamine antagonists
1.2.3 NK1 receptor antagonist
1.2.4 Antihistamines (H1 histamine receptor antagonists)
1.2.5 Cannabinoids
1.2.6 Benzodiazepines
1.2.7 Anticholinergics
1.2.8 Steroids
1.2.9 Others
1.3 Global Antiemetics Market Size by Type
1.3.1 Global Antiemetics Market Size Overview by Type (2018-2029)
1.3.2 Global Antiemetics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antiemetics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antiemetics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antiemetics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antiemetics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antiemetics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antiemetics Sales Breakdown by Type (2018-2023)
2 Global Antiemetics Market Competition by Company
2.1 Global Top Players by Antiemetics Sales (2018-2023)
2.2 Global Top Players by Antiemetics Revenue (2018-2023)
2.3 Global Top Players by Antiemetics Price (2018-2023)
2.4 Global Top Manufacturers Antiemetics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antiemetics Market Competitive Situation and Trends
2.5.1 Antiemetics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antiemetics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetics as of 2022)
2.7 Date of Key Manufacturers Enter into Antiemetics Market
2.8 Key Manufacturers Antiemetics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antiemetics Status and Outlook by Region
3.1 Global Antiemetics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antiemetics Historic Market Size by Region
3.2.1 Global Antiemetics Sales in Volume by Region (2018-2023)
3.2.2 Global Antiemetics Sales in Value by Region (2018-2023)
3.2.3 Global Antiemetics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antiemetics Forecasted Market Size by Region
3.3.1 Global Antiemetics Sales in Volume by Region (2024-2029)
3.3.2 Global Antiemetics Sales in Value by Region (2024-2029)
3.3.3 Global Antiemetics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antiemetics by Application
4.1 Antiemetics Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.1.4 Others
4.2 Global Antiemetics Market Size by Application
4.2.1 Global Antiemetics Market Size Overview by Application (2018-2029)
4.2.2 Global Antiemetics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antiemetics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antiemetics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antiemetics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antiemetics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antiemetics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antiemetics Sales Breakdown by Application (2018-2023)
5 North America Antiemetics by Country
5.1 North America Antiemetics Historic Market Size by Country
5.1.1 North America Antiemetics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antiemetics Sales in Volume by Country (2018-2023)
5.1.3 North America Antiemetics Sales in Value by Country (2018-2023)
5.2 North America Antiemetics Forecasted Market Size by Country
5.2.1 North America Antiemetics Sales in Volume by Country (2024-2029)
5.2.2 North America Antiemetics Sales in Value by Country (2024-2029)
6 Europe Antiemetics by Country
6.1 Europe Antiemetics Historic Market Size by Country
6.1.1 Europe Antiemetics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antiemetics Sales in Volume by Country (2018-2023)
6.1.3 Europe Antiemetics Sales in Value by Country (2018-2023)
6.2 Europe Antiemetics Forecasted Market Size by Country
6.2.1 Europe Antiemetics Sales in Volume by Country (2024-2029)
6.2.2 Europe Antiemetics Sales in Value by Country (2024-2029)
7 Asia-Pacific Antiemetics by Region
7.1 Asia-Pacific Antiemetics Historic Market Size by Region
7.1.1 Asia-Pacific Antiemetics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antiemetics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antiemetics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antiemetics Forecasted Market Size by Region
7.2.1 Asia-Pacific Antiemetics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antiemetics Sales in Value by Region (2024-2029)
8 Latin America Antiemetics by Country
8.1 Latin America Antiemetics Historic Market Size by Country
8.1.1 Latin America Antiemetics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antiemetics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antiemetics Sales in Value by Country (2018-2023)
8.2 Latin America Antiemetics Forecasted Market Size by Country
8.2.1 Latin America Antiemetics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antiemetics Sales in Value by Country (2024-2029)
9 Middle East and Africa Antiemetics by Country
9.1 Middle East and Africa Antiemetics Historic Market Size by Country
9.1.1 Middle East and Africa Antiemetics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antiemetics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antiemetics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antiemetics Forecasted Market Size by Country
9.2.1 Middle East and Africa Antiemetics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antiemetics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Antiemetics Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Antiemetics Products Offered
10.2.5 Merck Recent Development
10.3 Sanofi Aventis
10.3.1 Sanofi Aventis Company Information
10.3.2 Sanofi Aventis Introduction and Business Overview
10.3.3 Sanofi Aventis Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Aventis Antiemetics Products Offered
10.3.5 Sanofi Aventis Recent Development
10.4 Bristol Myers Squibb
10.4.1 Bristol Myers Squibb Company Information
10.4.2 Bristol Myers Squibb Introduction and Business Overview
10.4.3 Bristol Myers Squibb Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bristol Myers Squibb Antiemetics Products Offered
10.4.5 Bristol Myers Squibb Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Introduction and Business Overview
10.5.3 Eli Lilly Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly Antiemetics Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Antiemetics Products Offered
10.6.5 Pfizer Recent Development
10.7 Astellas
10.7.1 Astellas Company Information
10.7.2 Astellas Introduction and Business Overview
10.7.3 Astellas Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Astellas Antiemetics Products Offered
10.7.5 Astellas Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Introduction and Business Overview
10.8.3 Johnson & Johnson Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Antiemetics Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 Baxter
10.9.1 Baxter Company Information
10.9.2 Baxter Introduction and Business Overview
10.9.3 Baxter Antiemetics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Baxter Antiemetics Products Offered
10.9.5 Baxter Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antiemetics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antiemetics Industrial Chain Analysis
11.4 Antiemetics Market Dynamics
11.4.1 Antiemetics Industry Trends
11.4.2 Antiemetics Market Drivers
11.4.3 Antiemetics Market Challenges
11.4.4 Antiemetics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antiemetics Distributors
12.3 Antiemetics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
